C4X Discovery Holdings PLC Result of AGM (6557A)
2024年1月23日 - 10:57PM
RNSを含む英国規制内ニュース (英語)
TIDMC4XD
RNS Number : 6557A
C4X Discovery Holdings PLC
23 January 2024
C4X Discovery Holdings plc
("C4XD", "C4X Discovery" or the "Company")
Result of AGM
23 January 2024 - C4X Discovery Holdings plc (AIM: C4XD), a
pioneering Drug Discovery company, today announces that at its
Annual General Meeting, held today at 11.30 a.m., (GMT) all
resolutions were duly passed.
- Ends -
Contacts
C4X Discovery Holdings
Mo Noonan, Communications +44 (0)787 6444977
Panmure Gordon (UK) Limited (NOMAD and
Broker)
Freddy Crossley, Emma Earl (Corporate
Finance) +44 (0)20 7886 2500
Rupert Dearden (Corporate Broking)
C4X Discovery Media - ICR Consilium
Mary-Jane Elliott, Chris Gardner, Matthew
Neal +44 (0)203 709 5700
C4X Discovery Holdings
Notes to Editors:
About C4X Discovery
C4X Discovery (C4XD) is a pioneering Drug Discovery company,
combining scientific expertise with cutting-edge technologies to
efficiently deliver world--leading medicines. We have a highly
valuable and differentiated approach to Drug Discovery through our
enhanced molecular design and patient stratification capabilities,
generating small molecule drug candidates across multiple disease
indications focused on immuno-inflammation. We are advancing our
internal portfolio which ranges
from early-stage target opportunities to late-stage Drug
Discovery programmes and we have two commercially partnered
programmes with Sanofi and AstraZeneca, and one clinical stage
candidate which has been acquired by Indivior.
For more information visit us at www.c4xdiscovery.com or follow
us on twitter @C4XDiscovery.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGBXGDBSUDDGSX
(END) Dow Jones Newswires
January 23, 2024 08:57 ET (13:57 GMT)
C4x Discovery (LSE:C4XD)
過去 株価チャート
から 4 2024 まで 5 2024
C4x Discovery (LSE:C4XD)
過去 株価チャート
から 5 2023 まで 5 2024